Sterol balance in the Smith-Lemli-Opitz syndrome: Reduction in whole body cholesterol synthesis and normal bile acid production

Journal of Lipid Research

Volumn 41, Issue 9, 2000, Pages 1437-1447

  Steiner, Robert D ^a   Linck, Leesa M ^a   Flavell, Donna P ^b   Lin, Don S ^b   Connorb, William E ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Health and Science University   (Spain)

Author keywords

7 dehydrocholesterol; 8 dehydrocholesterol; Bacterial modification of sterols; Gas chromatography; Hypocholesterolemia; Metabolism of sterols; Multiple malformations; Plant sterols; Sterols

Indexed keywords

7 DEHYDROCHOLESTEROL; PHYTOSTEROL;

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHILD; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; GAS CHROMATOGRAPHY; GENE MUTATION; HUMAN; HYPOCHOLESTEROLEMIA; INFANT; MALE; NEWBORN; PHOTOOXIDATION; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME; STEROL METABOLISM; STEROL SYNTHESIS;

EID: 0033806452     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-2275(20)33456-8     Document Type: Article

References (62)

1. A newly recognized syndrome of multiple congenital anomalies
2. Smith-Lemli-Opitz syndrome-type II: Multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality
3. Smith-Lemli-Opitz syndrome
4. Smith-Lemli-Opitz (RSH) syndrome bibliography
5. Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents
6. Abnormal bile acids in the Smith-Lemli-Opitz syndrome
7. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism
8. Smith-Lemli-Opitz syndrome: A variable clinical and biochemical phenotype
9. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome
10. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome
11. Cholesterol defect in Smith-Lemli-Opitz syndrome
12. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome
13. Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3 beta-ol) in patients with Smith-Lemli-Opitz syndrome
14. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes
15. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes
16. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome
17. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome
18. Smith-Lemli-Opitz syndrome is caused by mutations in the 7- dehydrocholesterol reductase gene
19. The product of hedgehog autoproteolytic cleavage active in local and long-range signalling
20. Cholesterol modification of hedgehog signaling proteins in animal development
21. Hedgehog patterning activity: Role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain
22. Teratogen-mediated inhibition of target tissue response to Shh signaling
23. Relationship between abnormal cholesterol synthesis and retarded learning in rats
24. Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: A model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome
25. A cholesterol deficiency syndrome in humans
26. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: Report of clinical and biochemical findings in four patients and treatment in one patient
27. Cholesterol and bile acid replacement therapy in children and with Smith-Lemli-Opitz (Slo/Rsh) syndrome
28. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)
29. The interrelated effects of dietary cholesterol and fat upon human serum lipid levels
30. Experimental note: Sterol balance study conducted in the home
31. Changes in cholesterol metabolism in infants in response to dietary cholesterol and fat
32. Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral sterols
33. Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral sterols
34. Cholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition
35. The intestinal absorption of dietary cholesterol by hypercholesterolemic (type II) and normocholesterolemic humans
36. The long term effects of dietary cholesterol upon the plasma lipids, lipoproteins, cholesterol absorption and the sterol balance in man: The demonstration of feedback inhibition of cholesterol biosynthesis and increased bile acid excretion
37. The absorption of cholesterol and the sterol balance in the Tarahumara Indians of Mexico fed cholesterol-free and high cholesterol diets
38. Measurements of cholesterol turnover, synthesis and absorption in man, carried out by isotope kinetic and sterol balance methods
39. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: Effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver
40. Absorption and transport of shellfish sterols in human subjects
41. Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis
42. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome
43. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men
44. Inverse relationship between plasma cholestanol concentrations and bile acid synthesis in sitosterolemia
45. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters
46. 3-Methylglutaconic acidemia in Smith-Lemli-Opitz syndrome
47. Post-transcriptionai regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol
48. Oxylanosterols as modifiers of cholesterol biosynthesis
49. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts
50. Reduction in cholesterol and low density, lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia
51. Changes in cholesterol metabolism with dietary cholesterol in children with familial hypercholesterolaemia
52. The role of human growth hormone in the regulation of cholesterol and bile acid metabolism
53. Long-term changes in choIesteroI biosynthesis and the effect of plasmapheresis therapy in a hypercholesterolemia homozygote
54. Elevated cholesterol and bile acid synthesis in a young patient with homozygous familial hypercholesterolemia
55. The cholesterol turnover, synthesis and absorption in two sisters with familial hypercholesterolemia (type IIa)
56. Cholesterol excretion studies in familial hypercholesterolemic children and their normolipidemic siblings
57. Lipid metabolism in abetalipoproteinemia: A study of cholesterol absorption and sterol balance in two patients
58. Hypercholesterolemia associated with alpha-1 antitrypsin deficiency and hepatitis: Lipoprotein and apoprotein determinations, sterol balance and treatment
59. Comparison of patterns of fecal bile acid and neutral sterol between children and adults
60. RSH/Smith-Lemli-Opitz syndrome: Mutations and metabolic morphogenesis
61. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome
62. New treatment strategy for Smith-Lemli-Opitz syndrome